Guilan Li

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Dharminder Chauhan, Laurence Catley, Guilan Li et al. · Cancer Cell · 2005 · 698 citations · Full text

Medicine, Oncology, Pharmacology +14

Hematotoxicity in Workers Exposed to Low Levels of Benzene

Qing Lan, Luoping Zhang, Guilan Li et al. · Science · 2004 · 624 citations · Full text

Pharmacy, Hematology, Toxicology +9

A recurrent mutation in PALB2 in Finnish cancer families

Hannele Erkko, Bing Xia, Jenni Nikkilä et al. · Nature · 2007 · 461 citations

Medicine, Genetics, Molecular Genetics +10

Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells.

Dharminder Chauhan, Guilan Li, Reshma Shringarpure et al. · PubMed · 2003 · 230 citations

Medicine, Oncology, Pharmacology +17

Analysis of <i>PALB2</i> / <i>FANCN</i> -associated breast cancer families

Marc Tischkowitz, Bing Xia, Nelly Sabbaghian et al. · Proceedings of the National Academy of Sciences · 2007 · 212 citations · Full text

Life Sciences, Genetics, Oncology +16